Kazuki Tomura
Overview
Explore the profile of Kazuki Tomura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomura K, Sakamaki H, Nawata S, Ishida H, Tanaka K, Kogo M
Int J Clin Pharm
. 2024 Nov;
PMID: 39565452
Background: Pembrolizumab monotherapy significantly extends progression-free and overall survival compared to platinum-based chemotherapy for advanced non-small cell lung cancer (NSCLC), but also has a significant impact on medical costs. Aim:...
2.
Awaya M, Tanaka H, Suzuki A, Yamauchi R, Kusunoki Y, Tanaka N, et al.
Clin Nephrol
. 2021 Jul;
96(5):289-295.
PMID: 34308835
Aim: The new guidelines in Japan do not recommend a vancomycin (VCM) loading dose for patients with an estimated glomerular filtration rate (eGFR) 30 < and ≤ 80 mL×min×1.73m (moderate...
3.
Tomura K, Naito Y, Sunaga T, Kurihara T, Usuda M, Nagatani A, et al.
Yakugaku Zasshi
. 2018 Nov;
138(11):1397-1407.
PMID: 30381648
Sunitinib has been shown to offer clinical benefits during the treatment of advanced renal cell carcinoma. However, molecular targeting drugs are expensive and can have a significant impact on medical...
4.
Nagatani A, Ogawa Y, Sunaga T, Tomura K, Naito Y, Fujii N, et al.
Yakugaku Zasshi
. 2017 Feb;
137(2):221-225.
PMID: 28154335
Radiotherapy (RT) and chemoradiotherapy (CRT) is widely accepted as the standard treatment for head and neck cancer (HNC). Oral mucositis (OM) often develops as an adverse reaction in HNC patients...
5.
Tomura K, Kogo M, Inoue T, Kaneko K, Imawari M, Yoneyama K, et al.
Gan To Kagaku Ryoho
. 2007 Nov;
34(11):1807-13.
PMID: 18030014
Objective: To assess the cost-effectiveness of chemoradiotherapy (CRT) regimens for patients with esophageal cancer, we compared two regimens consisting of 5-fluorouracil (5-FU) and cisplatin (CDDP) or 5-FU and nedaplatin (CDGP)...